Tim Walbert (via Twitter)

FDA hands off its lat­est whirl­wind drug OK as Hori­zon hus­tles would-be block­buster to the mar­ket

The FDA isn’t let­ting its foot off the gas ped­al just be­cause it’s Jan­u­ary.

The agency came through with an ap­proval for Hori­zon Ther­a­peu­tics’ …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.